| Date Filed | Type | Description |
| 07/27/2023 |
4
| DUGGAN ROBERT W (10% Owner) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Exercised 1,667 options to buy
@ $5.95, valued at
$9.9k
|
|
| 07/07/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2023 |
4
| DUGGAN ROBERT W (10% Owner) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Exercised (in-or-at-the-money) 5,683,163 warrants
@ $2.05, valued at
$11.7M
Exercised (in-or-at-the-money) 81,025 warrants
@ $2.05, valued at
$166.1k
|
|
| 06/06/2023 |
4
| DUGGAN ROBERT W (10% Owner) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $5.95, valued at
$119k
Granted 39,731 options to buy
@ $5.95, valued at
$236.4k
|
|
| 05/10/2023 |
SC 13D/A
| DUGGAN ROBERT W reports a 68.7% stake in Pulse Biosciences, Inc. |
| 05/10/2023 |
4
| DUGGAN ROBERT W (10% Owner) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Bought 10,022,937 shares
@ $6.51, valued at
$65.2M
|
|
| 03/08/2023 |
4
| DUGGAN ROBERT W (CEO) has filed a Form 4 on Summit Therapeutics Inc.|
Txns:
| Bought 376,489,880 shares
@ $1.05, valued at
$395.3M
|
|
| 12/09/2022 |
SC 13D/A
| DUGGAN ROBERT W reports a 81.8% stake in Summit Therapeutics Inc. |
| 12/08/2022 |
4
| DUGGAN ROBERT W (CEO) has filed a Form 4 on Summit Therapeutics Inc.|
Txns:
| Acquired 9,346,434 shares
@ $0 |
|
| 08/18/2022 |
SC 13D/A
| DUGGAN ROBERT W reports a 81.2% stake in Summit Therapeutics Inc. |
| 08/18/2022 |
4
| DUGGAN ROBERT W (CEO) has filed a Form 4 on Summit Therapeutics Inc.|
Txns:
| Bought 94,849,203 shares
@ $0.97, valued at
$92M
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2021 |
SC 13D/A
| DUGGAN ROBERT W reports a 51.2% stake in Pulse Biosciences, Inc. |
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/14/2021 |
SC 13D/A
| DUGGAN ROBERT W reports a 70.8% stake in Summit Therapeutics Inc. |
| 05/11/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/22/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/26/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/30/2020 |
4
| DUGGAN ROBERT W (10% Owner) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Exercised (in-or-at-the-money) 376,065 warrants
@ $7.01, valued at
$2.6M
Exercised (in-or-at-the-money) 8,214 warrants
@ $7.01, valued at
$57.6k
|
|
| 11/10/2020 |
4
| DUGGAN ROBERT W (CEO) has filed a Form 4 on Summit Therapeutics Inc.|
Txns:
| Bought 14,071,856 shares
@ $3.34, valued at
$47M
|
|
| 11/10/2020 |
SC 13D/A
| DUGGAN ROBERT W reports a 69.9% stake in Summit Therapeutics Inc. |
| 10/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/28/2020 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 09/18/2020 |
3
| DUGGAN ROBERT W (See Remarks) has filed a Form 3 on Summit Therapeutics Inc. |
| 06/17/2020 |
SC 13D/A
| DUGGAN ROBERT W reports a 47.2% stake in Pulse Biosciences, Inc. |
| 06/17/2020 |
4
| DUGGAN ROBERT W (10% Owner) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Exercised (in-or-at-the-money) 2,507,112 shares
@ $7.01, valued at
$17.6M
Exercised (in-or-at-the-money) 54,761 shares
@ $7.01, valued at
$383.9k
Bought 376,065 warrants
@ $7.01, valued at
$2.6M
Bought 8,214 warrants
@ $7.01, valued at
$57.6k
|
|
| 05/19/2020 |
4
| DUGGAN ROBERT W (10% Owner) has filed a Form 4 on Pulse Biosciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $10.66, valued at
$213.2k
Granted 20,347 options to buy
@ $10.66, valued at
$216.9k
|
|
| 01/16/2020 |
SC 13D/A
| DUGGAN ROBERT W reports a 64.9% stake in Summit Therapeutics PLC |
|